Global Infertility Drugs Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Infertility Drugs Market was valued at $4.2 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 6.1% CAGR, to an estimated market size of $5.7 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global infertility drugs market comprises pharmaceutical formulations designed to treat reproductive dysfunctions in both men and women. The scope includes gonadotropins, aromatase inhibitors, selective estrogen receptor modulators (SERMs), and other hormonal therapies used to stimulate ovulation, regulate hormone levels, or improve sperm quality, particularly in conjunction with Assisted Reproductive Technology (ART) like IVF and IUI.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Infertility Drugs Market in the period 2025-30:
- Rising global prevalence of infertility is being driven by lifestyle factors such as high stress, obesity, and a structural trend toward delayed parenthood.
- The integration of Artificial Intelligence (AI) is revolutionizing the market by enabling personalized treatment protocols and optimizing drug dosages for better success rates.
- Expansion of government subsidies and insurance mandates, particularly in regions like Japan and various U.S. states, is significantly reducing financial barriers for patients.
- The emergence of biosimilars and novel long-acting injectable formulations is improving patient compliance while creating pricing pressure in established markets.
- A shift toward online pharmacies and telehealth platforms is increasing accessibility and providing privacy for patients facing social stigma regarding fertility issues.
- Increasing adoption of Assisted Reproductive Technology (ART) procedures like IVF is serving as a primary growth engine for high-potency fertility medications.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Gonadotropins
- Aromatase Inhibitors
- Other Drugs